print

Pharmaceuticals

WHY AND HOW WE USE NEUTRONS?

CASE STUDIES

"Neutrons have proven themselves to be a key resource for this project; we needed to analyse the p7 protein structure in a specific environment. Now we can take this deep understanding of the virus not only to devices like biosensors, but also to other fields, to study the behaviour of membrane proteins in lipid bilayers, for example.” Bruno Tillier, Managing Director, Synthelis

PRICE EXAMPLES

Prices can vary depending on the complexity of the measurement

  • SANS data: from 150 EUR/sample
  • Identification of crystalline planes (Laue diffraction pattern): from 100 EUR/sample
  •  In-situ (temperature, pressure) diffraction data: from 6 kEUR

NEWS CORNER

- News,Health,Chemistry,Industry - Pharmaceuticals,Scientific news,D16

A recently published study uses neutron and X-ray scattering to deepen our understanding of freeze-drying protein stabilisation processes, widely used in biopharmaceutical applications. The results obtained for a protein relevant for pharmaceutical…

- News,Industry,Industry - Pharmaceuticals,General news

Curium has just announced an agreement that adds ILL to their global irradiation portfolio to ensure continuous supply of lutetium-177 to benefit more than 100 000 cancer patients over the next five years

- Industry - Pharmaceuticals,General news,France,Switzerland

The Swiss company NOVARTIS announced at the Choose France Summit the desire to establish a partnership with the ILL, already a partner of other pharmaceutical companies for radioisotope production for cancer treatment and research. This is part of a…

- Health,Biology Health,Industry - Pharmaceuticals,Scientific news,D22,FIGARO,Austria,France,Italy,Sweden

Understanding the interactions of biomolecules such as proteins or drugs with the membrane of cells is important in biomedical research and for the pharmaceutical industry. The sensitivity of neutrons to hydrogen atoms make neutron scattering a…

- News,Health,Biology Health,Industry - Pharmaceuticals,Scientific news,D11

Courtesy of Alison Oliver (STFC,RAL,ISIS)

- News,Health,Biology Health,Industry - Pharmaceuticals,Scientific news,D22,Sweden,United Kingdom
- News,Health,Industry - Pharmaceuticals,Scientific news,FIGARO
- Environment,Industry - Pharmaceuticals,Scientific news,D50-NeXT,Germany
- Health,Biology Health,Industry - Pharmaceuticals,Soft matter,Scientific news,IN13,IN16B,France,Italy
- News,Biology Health,Industry - Pharmaceuticals,Scientific news,DALI,LADI-III,USA